Have you registered for the Alliance Fall Group Meeting in Chicago taking place November 5-7? Registration is open to attend virtually or in person. Visit https://lnkd.in/g5CgRyBq to register. #AllianceFall25 #NCI #NCTN #NCORP #CancerResearch
Alliance for Clinical Trials in Oncology
Research Services
Chicago, IL 11,460 followers
Reducing the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines.
About us
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments. The Alliance is a member of the NCI National Clinical Trials Network (NCTN) and also serves as a research base for the NCI Community Research Oncology Program (NCORP). The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Our mission is three-fold: To conduct high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; To further our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; and To provide a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.
- Website
-
http://www.AllianceNCTN.org
External link for Alliance for Clinical Trials in Oncology
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Chicago, IL
- Type
- Nonprofit
- Founded
- 2011
- Specialties
- Cancer Research , Cancer Control, Cancer Prevention , Cancer Treatment, Research Network, Clinical Practice, Clinical Research, Translational Research , and Clinical Trials
Locations
-
Primary
Get directions
125 S. Wacker Drive, Suite 1600,
Chicago, IL 60606, US
-
Get directions
221 Longwood Avenue, Room 108
Boston, MA 02115, US
Employees at Alliance for Clinical Trials in Oncology
Updates
-
Priscilla Brastianos, MD, of Massachusetts General Hospital, leads Alliance A071701, a trial to see how well #genetictesting works to better tailor treatment for people with solid tumors that have spread to the brain. To learn more about this trial, visit https://lnkd.in/gB37Qm_a #NCI #NCTN #CancerResearch #glioblastoma #genomics
-
-
New trial! Deepak Kilari, MD, from the Medical College of Wisconsin leads Alliance A032302, the ASPIRE clinical trial, to see if adding chemotherapy to hormone therapy improves survival in men with metastic prostate cancer. To learn more, visit https://lnkd.in/gRvWRXVP.
-
-
A groundbreaking new study from the Alliance for Clinical Trials in Oncology aims to test whether digital tools and chatbot technology can help young adult cancer survivors get the genetic counseling they need to better understand future health risks to themselves and family members. Read the news story at https://lnkd.in/gpFDfzu5.
-
-
For #TrialTuesday, Alliance researcher Jacob Sands, MD, of the Dana-Farber Cancer Institute, leads Alliance A081801 (ALCHEMIST Chemo-IO), a trial testing if adding #immunotherapy to #chemotherapy after surgery improves survival in non-small cell #lungcancer. To learn more, visit https://lnkd.in/d6zxAWK #NCI #NCTN #NSCLC #LCSM
-
-
Happening today—Sept. 29 at 12 pm CT! Join Alliance researchers for a public webinar highlighting the Best of Alliance At ASCO 2025. Investigators will share key trial results & discuss what they mean for the future of cancer treatment - https://lnkd.in/g9Pserjz #NCI #NCTN #NCORP
-
-
Hats off to Alliance researchers Andrea Apolo, MD (NCI), Jennifer Chan, MD, MPH (Dana-Farber), and colleagues on publishing results from the CABINET (A021602) and AMBASSADOR (A031501) Alliance trials in The New England Journal of Medicine. Read the articles at https://lnkd.in/gXrvv62g and https://lnkd.in/gUf7mpaz #NCI #NCTN #CancerResearch #NETS #bladdercancer
-
-
Sascha Tuchman, MD, of UNC Lineberger Comprehensive Cancer Center, leads Alliance A062102 comparing iberdomide maintenance therapy to disease monitoring to improve survival in patients with multiple #myeloma. To learn more, visit https://lnkd.in/gam3h52J. #NCI #NCTN #CancerResearch
-
-
Alliance researcher Angela Bradbury, MD, of the University of Pennsylvania Perelman School of Medicine, leads Alliance A232301CD to test whether a digital chatbot intervention is as effective as standard remote genetic services in increasing genetic counseling and testing uptake among adolescent and young adult cancer patients. https://lnkd.in/gC4cc7Py #NCI #NCORP #AYA
-
-
For #TrialTuesday, Anne Beaven, MD, of UNC Lineberger Comprehensive Cancer Center, leads Alliance A052101, a study to see if older people with mantle cell #lymphoma can receive fewer treatments of zanubrutinib while in remission. To learn more about this study, visit https://lnkd.in/g9SJKMwH. #NCI #NCTN #CancerResearch
-